Haemonetics Income Statement (2009-2025) | HAE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Apr2021	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	225.03M	228.53M	239.90M	259.77M	265.00M	261.46M	297.49M	305.30M	304.42M	311.33M	318.18M	336.25M	343.29M	336.17M	345.51M	348.54M	330.60M	321.39M	327.31M	338.97M
Cost of Revenue (Quarter)	143.22M	120.44M	117.36M	121.20M	128.69M	119.19M	139.61M	146.59M	148.17M	144.07M	147.67M	158.38M	167.38M	161.25M	158.07M	155.00M	137.55M	129.15M	132.57M	136.58M
Gross Profit (Quarter)	81.81M	108.08M	122.54M	138.56M	136.31M	142.26M	157.88M	158.71M	156.25M	167.26M	170.51M	177.87M	175.91M	174.92M	187.44M	193.55M	193.05M	192.24M	194.74M	202.39M
Operating items
Amortization - Intangibles (Quarter)	8.63M	12.38M	11.40M	12.15M	11.48M	8.37M	8.22M	8.08M	7.97M	7.47M	7.22M	6.91M	10.43M	12.47M	12.26M	12.23M	11.30M	11.39M	11.18M	10.93M
Research & Development (Quarter)	10.84M	12.70M	10.85M	10.04M	13.21M	10.90M	10.90M	12.69M	15.64M	12.65M	12.66M	13.27M	15.86M	14.45M	14.14M	15.83M	18.30M	16.26M	14.87M	14.19M
Selling, General & Administrative (Quarter)	83.71M	91.22M	75.78M	80.73M	92.42M	92.23M	92.03M	94.66M	97.76M	93.48M	115.32M	111.71M	111.26M	108.25M	106.95M	106.46M	115.14M	110.72M	101.61M	109.15M
Other Operating Expenses (Quarter)	0.20M	9.60M					0.38M			7.47M	7.22M	6.91M	18.84M	12.47M	14.65M	12.23M	-11.73M	11.39M	19.77M	11.65M
Operating Expenses (Quarter)	102.98M	106.69M	98.03M	102.91M	117.11M	111.50M	111.15M	115.43M	120.99M	113.61M	135.21M	131.89M	145.96M	135.17M	135.74M	134.52M	121.72M	138.37M	136.25M	134.99M
Operating Income (Quarter)	-21.18M	1.39M	24.51M	35.65M	19.20M	30.77M	46.73M	43.28M	35.26M	53.66M	35.30M	45.98M	29.94M	39.76M	51.70M	59.03M	71.33M	53.87M	58.49M	67.40M
EBIT (Quarter)	-21.18M	1.39M	24.51M	35.65M	19.20M	30.77M	46.73M	43.28M	35.26M	53.66M	35.30M	45.98M	29.94M	39.76M	51.70M	59.03M	71.33M	53.87M	58.49M	67.40M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	-6.22M	-4.40M	-4.59M	-4.26M	-3.87M	-5.27M	-5.67M	-1.05M	-2.63M	-2.07M	-2.47M	-1.95M	-6.53M	6.96M	-6.99M	-9.11M	-0.60M	-8.70M	-7.21M	-7.42M
Non Operating Income (Quarter)	-6.22M	-4.40M	-4.59M	-4.26M	-3.87M	-5.27M	-5.67M	-1.05M	-2.63M	-2.07M	-2.47M	-1.95M	-6.53M	6.96M	-6.99M	-9.11M	-0.60M	-8.70M	-7.21M	-7.42M
Net income details
EBT (Quarter)	-27.40M	-3.01M	19.92M	31.39M	15.33M	25.49M	41.06M	42.22M	32.63M	51.59M	32.83M	44.03M	23.41M	46.71M	44.70M	49.92M	70.74M	45.17M	51.28M	59.98M
Tax Provisions (Quarter)	-16.36M	1.45M	5.07M	8.20M	5.55M	5.60M	7.86M	9.28M	3.24M	10.55M	7.90M	12.79M	3.05M	8.34M	10.87M	12.40M	12.76M	11.14M	12.60M	15.20M
Profit After Tax (Quarter)	-11.04M	-4.45M	14.86M	23.23M	9.74M	19.88M	33.20M	32.94M	29.38M	41.04M	24.91M	31.24M	20.37M	38.37M	33.83M	37.49M	57.98M	34.03M	38.68M	44.74M
Income from Continuing Operations (Quarter)	-11.04M	-4.45M	14.86M	23.19M	9.77M	19.89M	33.20M	32.94M	29.38M	41.04M	24.93M	31.24M	20.37M	38.37M	33.83M	37.52M	57.97M	34.03M	38.68M	44.77M
Consolidated Net Income (Quarter)	-11.04M	-4.45M	14.86M	23.19M	9.77M	19.89M	33.20M	32.94M	29.38M	41.04M	24.93M	31.24M	20.37M	38.37M	33.83M	37.52M	57.97M	34.03M	38.68M	44.77M
Income towards Parent Company (Quarter)	-11.04M	-4.45M	14.86M	23.19M	9.77M	19.89M	33.20M	32.94M	29.38M	41.04M	24.93M	31.24M	20.37M	38.37M	33.83M	37.52M	57.97M	34.03M	38.68M	44.77M
Net Income towards Common Stockholders (Quarter)	-11.04M	-4.45M	14.86M	23.19M	9.77M	19.89M	33.20M	32.94M	29.38M	41.04M	24.93M	31.24M	20.37M	38.37M	33.83M	37.52M	57.97M	34.03M	38.68M	44.77M
Additional items
EPS (Basic) (Quarter)	-0.22	-0.09	0.29	0.45	0.19	0.39	0.65	0.65	0.58	0.81	0.49	0.62	0.40	0.75	0.66	0.75	1.17	0.71	0.81	0.96
EPS (Weighted Average and Diluted) (Quarter)	-0.22	-0.09	0.29	0.45	0.19	0.38	0.64	0.64	0.57	0.80	0.48	0.61	0.40	0.74	0.66	0.74	1.17	0.70	0.81	0.95
Shares Outstanding (Weighted Average) (Quarter)	50.69M	50.94M	51.04M	51.09M	51.05M	51.22M	50.95M	50.90M	50.78M	50.54M	50.63M	50.77M	50.71M	50.94M	50.90M	50.29M	50.33M	48.11M	47.59M	47.50M
Shares Outstanding (Diluted Average) (Quarter)	51.29M	50.94M	51.36M	51.34M	51.35M	51.68M	51.62M	51.49M	51.42M	51.34M	51.37M	51.45M	51.40M	51.56M	51.40M	50.64M	50.73M	48.35M	47.66M	46.99M
EBITDA (Quarter)	-21.18M	-4.01M	14.42M	23.42M	19.20M	13.11M	25.66M	37.40M	35.26M	41.91M	21.72M	39.56M	29.94M	31.34M	41.93M	16.56M	71.33M	53.87M	58.49M	67.40M
Interest Expenses (Quarter)
Tax Rate (Quarter)	59.70%	-48.07%	25.43%	26.12%	36.24%	21.97%	19.15%	21.98%	9.94%	20.45%	24.06%	29.04%	13.01%	17.85%	24.32%	24.84%	18.04%	24.66%	24.57%	25.34%

Research Tools

Haemonetics Income Statement (2009-2025) | HAE

Create an account

Sign In

Reset Password